Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Biomarkers in urothelial carcinoma of the bladder: the potential cross-talk between transforming growth factor-β1 and estrogen receptor β/androgen receptor pathways.

Xu Y, Zhang NZ, Chen J, Yuan HQ.

Med Hypotheses. 2013 Jun;80(6):716-8. doi: 10.1016/j.mehy.2013.02.018. Epub 2013 Mar 9.

PMID:
23490202
2.

Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.

Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S.

BJU Int. 2012 Jun;109(11):1716-26. doi: 10.1111/j.1464-410X.2011.10706.x. Epub 2012 Jan 5.

3.

Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression.

Tuygun C, Kankaya D, Imamoglu A, Sertcelik A, Zengin K, Oktay M, Sertcelik N.

Urol Oncol. 2011 Jan-Feb;29(1):43-51. doi: 10.1016/j.urolonc.2009.01.033. Epub 2009 Apr 16.

PMID:
19372057
4.

Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.

Munari E, Fujita K, Faraj S, Chaux A, Gonzalez-Roibon N, Hicks J, Meeker A, Nonomura N, Netto GJ.

Hum Pathol. 2013 Dec;44(12):2668-76. doi: 10.1016/j.humpath.2013.07.008. Epub 2013 Sep 27.

PMID:
24074531
5.
6.

Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.

Williams MD, Roberts D, Blumenschein GR Jr, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK.

Am J Surg Pathol. 2007 Nov;31(11):1645-52.

PMID:
18059220
7.

Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium.

Lin C, Yin Y, Stemler K, Humphrey P, Kibel AS, Mysorekar IU, Ma L.

Cancer Res. 2013 Oct 1;73(19):5914-25. doi: 10.1158/0008-5472.CAN-12-4198. Epub 2013 Aug 8.

8.

Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder.

Bolenz C, Lotan Y, Ashfaq R, Shariat SF.

Eur Urol. 2009 Dec;56(6):1093-5. doi: 10.1016/j.eururo.2009.06.032. Epub 2009 Jul 7. No abstract available.

PMID:
19596509
9.

TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.

Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.

Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

PMID:
18163430
10.

Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.

Downes MR, Torlakovic EE, Aldaoud N, Zlotta AR, Evans AJ, van der Kwast TH.

J Clin Pathol. 2013 Sep;66(9):779-86. doi: 10.1136/jclinpath-2013-201586. Epub 2013 Jun 17.

PMID:
23775437
11.

Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.

Yu CP, Ho JY, Huang YT, Cha TL, Sun GH, Yu DS, Chang FW, Chen SP, Hsu RJ.

PLoS One. 2013;8(2):e56667. doi: 10.1371/journal.pone.0056667. Epub 2013 Feb 27.

12.

Estrogen receptor-β expression and pharmacological targeting in bladder cancer.

Kauffman EC, Robinson BD, Downes M, Marcinkiewicz K, Vourganti S, Scherr DS, Gudas LJ, Mongan NP.

Oncol Rep. 2013 Jul;30(1):131-8. doi: 10.3892/or.2013.2416. Epub 2013 Apr 23.

13.

Expression of transforming growth factor beta1 and its receptors in normal human urothelium and human transitional cell carcinomas.

Izadifar V, de Boer WI, Muscatelli-Groux B, Maillé P, van der Kwast TH, Chopin DK.

Hum Pathol. 1999 Apr;30(4):372-7.

PMID:
10208456
14.

Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.

Stope MB, Popp SL, Knabbe C, Buck MB.

Breast Cancer Res Treat. 2010 Apr;120(2):357-67. doi: 10.1007/s10549-009-0393-2. Epub 2009 Apr 16.

PMID:
19370415
16.

Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.

Zheng Y, Izumi K, Yao JL, Miyamoto H.

Endocr Relat Cancer. 2011 Jul 4;18(4):451-64. doi: 10.1530/ERC-11-0010. Print 2011 Aug.

17.

Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor.

Izumi K, Zheng Y, Li Y, Zaengle J, Miyamoto H.

Int J Oncol. 2012 Nov;41(5):1587-92. doi: 10.3892/ijo.2012.1593. Epub 2012 Aug 21.

18.

Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.

Abou-Shady M, Baer HU, Friess H, Berberat P, Zimmermann A, Graber H, Gold LI, Korc M, Büchler MW.

Am J Surg. 1999 Mar;177(3):209-15.

PMID:
10219856
19.

TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal.

Shaker O, Hammam O, Wishahi M, Roshdi M.

Urol Oncol. 2013 Apr;31(3):372-8. doi: 10.1016/j.urolonc.2011.02.003. Epub 2011 Mar 23.

PMID:
21429769

Supplemental Content

Support Center